Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Neoadjuvant therapy with bevacizumab
Thomas Gruenberger, Birgit Gruenberger, Werner Scheithauer
Journal of Surgical Oncology
|
February 24, 2009
Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients
Dietmar Tamandl, Birgit Gruenberger, Beata Herberger, et al.
Anticancer Research
|
July 24, 2010
Pharmacokinetics of irinotecan in combination with biweekly cetuximab in patients with advanced colorectal cancer
Martin Czejka, Birgit Gruenberger, Andreas Kiss, et al.
BMC Cancer
|
April 29, 2008
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
Birgit Gruenberger, Werner Scheithauer, Robert Punzengruber, et al.
Annals of Surgical Oncology
|
August 8, 2008
Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, et al.
Annals of Surgical Oncology
|
September 17, 2010
Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy
Dietmar Tamandl, Markus Klinger, Sandra Eipeldauer, et al.
Annals of Surgery
|
June 22, 2010
Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study
Dietmar Tamandl, Birgit Gruenberger, Markus Klinger, et al.
Anticancer Research
|
July 2, 2014
Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab
Andre Farkouh, Werner Scheithauer, Philipp Buchner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels
Christine Brostjan, Kristina Gebhardt, Birgit Gruenberger, et al.
Annals of Surgical Oncology
|
October 18, 2014
CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases
Stefan Stremitzer, Judith Stift, Alexandra Graf, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Neoadjuvant therapy with bevacizumab
Thomas Gruenberger, Birgit Gruenberger, Werner Scheithauer
Journal of Surgical Oncology
|
February 24, 2009
Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients
Dietmar Tamandl, Birgit Gruenberger, Beata Herberger, et al.
Anticancer Research
|
July 24, 2010
Pharmacokinetics of irinotecan in combination with biweekly cetuximab in patients with advanced colorectal cancer
Martin Czejka, Birgit Gruenberger, Andreas Kiss, et al.
BMC Cancer
|
April 29, 2008
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
Birgit Gruenberger, Werner Scheithauer, Robert Punzengruber, et al.
Annals of Surgical Oncology
|
August 8, 2008
Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, et al.
Annals of Surgical Oncology
|
September 17, 2010
Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy
Dietmar Tamandl, Markus Klinger, Sandra Eipeldauer, et al.
Annals of Surgery
|
June 22, 2010
Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study
Dietmar Tamandl, Birgit Gruenberger, Markus Klinger, et al.
Anticancer Research
|
July 2, 2014
Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab
Andre Farkouh, Werner Scheithauer, Philipp Buchner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels
Christine Brostjan, Kristina Gebhardt, Birgit Gruenberger, et al.
Annals of Surgical Oncology
|
October 18, 2014
CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases
Stefan Stremitzer, Judith Stift, Alexandra Graf, et al.
Page
of 4